AU2001271998A1 - Detection and treatment of polycystic kidney disease - Google Patents

Detection and treatment of polycystic kidney disease

Info

Publication number
AU2001271998A1
AU2001271998A1 AU2001271998A AU7199801A AU2001271998A1 AU 2001271998 A1 AU2001271998 A1 AU 2001271998A1 AU 2001271998 A AU2001271998 A AU 2001271998A AU 7199801 A AU7199801 A AU 7199801A AU 2001271998 A1 AU2001271998 A1 AU 2001271998A1
Authority
AU
Australia
Prior art keywords
detection
treatment
kidney disease
polycystic kidney
polycystic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271998A
Inventor
Gregory G. Germino
Bunyong Phakdeekitcharoen
Terry J. Watnick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
School of Medicine of Johns Hopkins University
Original Assignee
Johns Hopkins University
School of Medicine of Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University, School of Medicine of Johns Hopkins University filed Critical Johns Hopkins University
Publication of AU2001271998A1 publication Critical patent/AU2001271998A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001271998A 2000-07-13 2001-07-13 Detection and treatment of polycystic kidney disease Abandoned AU2001271998A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21826100P 2000-07-13 2000-07-13
US60/218,261 2000-07-13
US28369101P 2001-04-13 2001-04-13
US60/283,691 2001-04-13
PCT/US2001/022035 WO2002006529A2 (en) 2000-07-13 2001-07-13 Detection and treatment of polycystic kidney disease

Publications (1)

Publication Number Publication Date
AU2001271998A1 true AU2001271998A1 (en) 2002-01-30

Family

ID=26912733

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271998A Abandoned AU2001271998A1 (en) 2000-07-13 2001-07-13 Detection and treatment of polycystic kidney disease

Country Status (5)

Country Link
US (4) US7553644B2 (en)
JP (2) JP2004504038A (en)
AU (1) AU2001271998A1 (en)
CA (2) CA2395781C (en)
WO (1) WO2002006529A2 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2395781C (en) * 2000-07-13 2010-04-13 The Johns Hopkins University School Of Medicine Detection and treatment of polycystic kidney disease
US6916619B2 (en) 2001-10-12 2005-07-12 Athena Diagnostics, Inc. Compositions and methods for genetic analysis of polycystic kidney disease
US7273701B2 (en) 2001-10-12 2007-09-25 Athena Diagnostics, Inc. Compositions and methods for genetic analysis of polycystic kidney disease
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
US20050090001A1 (en) * 2003-10-07 2005-04-28 Parker Stephen H. Cell lines and methods for producing proteins
US7141376B2 (en) * 2004-05-28 2006-11-28 Lyons Leslie A Carrier tests for polycystic kidney disease in the cat
GB0523659D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
CA3081362C (en) 2006-07-24 2024-04-09 Athena Diagnostics, Inc. Method of detecting the occurrence of adpkd based on presence of nucleotide sequence alteration in pkd1
US8283351B2 (en) * 2007-04-02 2012-10-09 Institute For Oneworld Health Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof
WO2009131951A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
US8207205B2 (en) 2008-04-21 2012-06-26 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
WO2009131947A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising pyridazine derivatives
US20090264433A1 (en) * 2008-04-21 2009-10-22 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Triazine Derivatives
WO2010033626A1 (en) * 2008-09-19 2010-03-25 Institute For Oneworld Health Compounds, compositions and methods comprising imidazole and triazole derivatives
US8511216B2 (en) * 2009-03-30 2013-08-20 Kanzaki Kokyukoki Mfg. Co., Ltd. Hydraulic actuator unit
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
EP2635707B1 (en) 2010-11-05 2019-03-27 Kyoto University Method of examining polycystic kidney disease and method of screening for therapeutic agent of the disease
JP5717128B2 (en) * 2010-11-24 2015-05-13 国立大学法人東北大学 Chromosomal dominant polycystic kidney determination method and prophylactic / therapeutic drug screening method
WO2013019169A1 (en) 2011-08-01 2013-02-07 Institute For Oneworld Health Phosphate prodrugs
GB201410693D0 (en) 2014-06-16 2014-07-30 Univ Southampton Splicing modulation
EP3219809B1 (en) * 2014-09-03 2021-10-27 Otsuka Pharmaceutical Co., Ltd. Pathology determination assistance device, method, program and storage medium
KR102620328B1 (en) 2014-10-03 2024-01-02 콜드스프링하버러보러토리 Targeted augmentation of nuclear gene output
JP6723924B2 (en) 2014-11-19 2020-07-15 大塚製薬株式会社 Primer set and method for amplifying exons of PKD1 gene and PKD2 gene
CA2982436C (en) 2015-03-13 2023-09-12 Indiana University Research And Technology Corporation Targeting cgmp-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods
CN104975081B (en) * 2015-06-01 2019-03-01 南京市妇幼保健院 Detect amplimer, kit and its detection method of PKD1 gene mutation
KR20220105174A (en) 2015-10-09 2022-07-26 유니버시티 오브 사우스앰톤 Modulation of gene expression and screening for deregulated protein expression
WO2017106377A1 (en) 2015-12-14 2017-06-22 Cold Spring Harbor Laboratory Antisense oligomers for treatment of autosomal dominant mental retardation-5 and dravet syndrome
US11096956B2 (en) 2015-12-14 2021-08-24 Stoke Therapeutics, Inc. Antisense oligomers and uses thereof
CN106995851B (en) * 2017-04-25 2020-07-03 郑州大学第一附属医院 PCR primer for amplifying PKD1 exon ultra-long fragment, kit for detecting PKD1 gene mutation and application
SG10202108375XA (en) 2017-08-25 2021-09-29 Stoke Therapeutics Inc Antisense oligomers for treatment of conditions and diseases
DE102018103215B3 (en) * 2018-02-13 2019-08-14 Gna Biosolutions Gmbh Method and device for extracting a nucleic acid from a sample fluid
US20230287410A1 (en) 2020-05-11 2023-09-14 Stoke Therapeutics, Inc. Opa1 antisense oligomers for treatment of conditions and diseases
CA3208118A1 (en) * 2021-01-14 2022-07-21 Mayo Foundation For Medical Education And Research Treating diseases and improving nucleic acid delivery
WO2023230167A1 (en) * 2022-05-25 2023-11-30 Yale University Methods of treating, ameliorating and/or preventing polycystic kidney disease and polycystic liver disease
CN116732168B (en) * 2023-08-04 2023-11-03 北京贝瑞和康生物技术有限公司 Method and kit for detecting multiple mutations of autosomal dominant polycystic kidney
CN117143997B (en) * 2023-10-31 2024-02-23 北京中仪康卫医疗器械有限公司 Primer set, kit and detection method for PKD1 gene mutation detection

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
DE69433811T2 (en) * 1993-01-07 2005-06-23 Sequenom, Inc., San Diego DNA SEQUENCING BY MASS SPECTROMONY
US5837832A (en) * 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5472672A (en) * 1993-10-22 1995-12-05 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and method for polymer synthesis using arrays
AU1322695A (en) 1993-12-24 1995-07-17 Erasmus University Rotterdam Polycystic kidney disease 1 gene and uses thereof
US5654170A (en) * 1994-10-12 1997-08-05 Johns Hopkins University Polycystic kidney disease gene
US6867288B1 (en) * 1994-10-12 2005-03-15 Genzyme Corporation Polycystic kidney disease gene
US6071717A (en) * 1995-01-31 2000-06-06 Genzyme Corporation Polycystic kidney disease gene and protein
AU2809897A (en) * 1996-04-23 1997-11-12 Wistar Institute Of Anatomy And Biology, The Novel human cytomegalovirus dna constructs and uses therefor
US6031088A (en) 1996-05-23 2000-02-29 Albert Einstein College Of Medicine Of Yeshiva University Polycystic kidney disease PKD2 gene and uses thereof
CA2254083A1 (en) * 1996-05-24 1997-11-27 Genzyme Corporation Polycystic kidney disease gene
AU762361B2 (en) * 1997-03-13 2003-06-26 First Opinion Corporation Disease management system
US6297010B1 (en) * 1998-01-30 2001-10-02 Genzyme Corporation Method for detecting and identifying mutations
US6362326B1 (en) * 1998-12-22 2002-03-26 Smithkline Beecham Corporation 11 cby genomic sequence
IT1304060B1 (en) * 1998-12-29 2001-03-07 St Microelectronics Srl LEVEL VARIATOR FOR MULTIPLE POWER VOLTAGE CIRCUIT
CA2395781C (en) * 2000-07-13 2010-04-13 The Johns Hopkins University School Of Medicine Detection and treatment of polycystic kidney disease

Also Published As

Publication number Publication date
US8530161B2 (en) 2013-09-10
US20030008288A1 (en) 2003-01-09
CA2395781C (en) 2010-04-13
JP5536005B2 (en) 2014-07-02
CA2697031C (en) 2017-10-31
US7553644B2 (en) 2009-06-30
US20060246504A1 (en) 2006-11-02
CA2395781A1 (en) 2002-01-24
WO2002006529A2 (en) 2002-01-24
JP2004504038A (en) 2004-02-12
WO2002006529A3 (en) 2003-06-26
US20140037652A1 (en) 2014-02-06
CA2697031A1 (en) 2002-01-24
JP2012070736A (en) 2012-04-12
US20170321278A1 (en) 2017-11-09
US9670543B2 (en) 2017-06-06

Similar Documents

Publication Publication Date Title
AU2001271998A1 (en) Detection and treatment of polycystic kidney disease
AUPP784398A0 (en) Kidney disease detection and treatment
AU2002338265A1 (en) Molecules for disease detection and treatment
AU2002323210A1 (en) Bio-synthetic photostimulators and methods of use
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2002241520A1 (en) Blood assessment of injury
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002220151A1 (en) Method and system for the detection of heart disease
AU2001288864A1 (en) Ultrasonic based detection of catheter contact and alignment
AU2002237667A1 (en) Methods for the treatment and prevention of urinary stone disease
AU2002220266A1 (en) Methods for the identification and the treatment of cardiovascular disease
AU6887101A (en) Copolymers and methods of treating prion-related diseases
AU2002329784A1 (en) Molecules for disease detection and treatment
AU2002213164A1 (en) Detection of dna damage
AU2002214189A1 (en) Methods of identifying inhibitory compounds and uses thereof
AU2001245414A1 (en) Treatment of allergies
AU2002364890A1 (en) Molecules for disease detection and treatment
AU2001241709A1 (en) Molecules for disease detection and treatment
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2002347899A1 (en) Molecules for disease detection and treatment
AU2002243539A1 (en) Molecules for disease detection and treatment
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2001268153A1 (en) Processing of plasmid-containing fluids
AU2002353823A1 (en) Detection and treatment of intravascular lesions
AU2001253024A1 (en) Diagnosis and treatment of gastrointestinal disease